Abstract
An HPLC-based method with ultraviolet detection has been developed for determining the new cardiotropic drug protecor in the blood and applied to monitoring of the drug pharmacokinetics after intravenous administration in experimental animals (rabbits and beagle dogs). Ahigh initial concentration of protecor in the blood plasma, followed by rapid drug elimination has been observed after administration in a single dose to beagles (25 mg/kg) and rabbits (100 mg/kg). The drug half-elimination time was 0.47 and 0.32 h for dogs and rabbits, respectively.
Similar content being viewed by others
References
L. N. Sernov and N. M. Mitrokhin, Bulletin of the All-Russia Scientific Center for Safety Testing of Biologically Active Substances [in Russian], Moscow (2000), pp. 32–43.
L. N. Sernov, L. D. Smirnov, and O. G. Kesarev, Abstracts of Papers. The 5th All-Russia Congress “Humans and Drugs” [in Russian], Moscow (1998), p. 619.
I. I. Miroshnichenko, I. I. Tyulyaev, and A. P. Zuev, Bioaccessibility of Drugs [in Russiaqn], Gramotei, Moscow (2003).
V. N. Solov’ev, A. A. Firsov, and V. A. Filov, Pharmacokinetics [in Russian], Meditsina, Moscow (1980).
Author information
Authors and Affiliations
Additional information
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 40, No. 12, pp. 44–46, December, 2006.
Rights and permissions
About this article
Cite this article
Ptitsina, S.N., Bobrov, V.I., Serov, L.N. et al. HPLC determination of the new cardiotropic drug protecor in blood serum of animals. Pharm Chem J 40, 683–685 (2006). https://doi.org/10.1007/s11094-006-0219-z
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11094-006-0219-z